ArticleOncotarget2019
Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab.
Anna Kathrin Stüven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOncotarget2019
Anna Kathrin Stüven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.